HC Wainwright & Co. initiated coverage on Sio Gene Therapies with a new price target

4/30/21 6:11:58 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. initiated coverage of Sio Gene Therapies with a rating of Buy and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SIOX

Date	Price Target	Rating	Analyst
2/1/2022	$10.00 → $7.00	Buy	HC Wainwright & Co.
2/1/2022	$6.00 → $1.00	Outperform → Market Perform	SVB Leerink
10/21/2021	$8.00 → $10.00	Buy	HC Wainwright & Co.
8/12/2021	$7.00 → $6.00	Outperform	SVB Leerink
7/12/2021	$12.50	Buy	Chardan Capital Markets